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Nanoparticles (NPs) are known for their 
unique characteristics, including small 
size, large surface area, and high reactivity. 
Although these charac  teristics make NPs 
attractive for various medical and techno-
logical applications, they may also affect the 
potential toxicity of NPs. Indeed, various 
studies have shown that, on an equal-mass 
basis, NPs induce stronger toxic responses 
than do larger-size particles of the same 
chemical composition (de Haar et al. 2006; 
Nurkiewicz et al. 2008; Oberdörster et al. 
2005). Considering the rapid growth of nano-
technology, it is critical to evaluate the poten-
tial health risks associated with NP exposure.
Human exposure to NPs is possible via 
various routes (i.e., dermal, ingestion, injec-
tion for medical purposes), but inhalation 
is considered the major route of exposure 
for NPs, especially in occupational settings 
(Medina et al. 2007; Oberdörster et al. 2005). 
Therefore, knowledge gained from toxicologi-
cal studies with ambient nano  sized (ultrafine) 
particles has been used as a valuable data-
base for predicting the toxicology of NPs 
(Oberdörster et al. 2007). Because there have 
been reports of associations between inhaled 
ambient ultrafine particles and increased 
risk of cardiopulmonary diseases (Pope et al. 
2004), it has been suggested that inhaled NPs 
might have the potential to induce systemic 
cardio  vascular toxicity as well. In support of 
this notion, a few recent studies have reported 
the cardio  vascular effects of NPs after expo-
sure via the pulmonary route (LeBlanc et al. 
2010; Li et al. 2007; Nurkiewicz et al. 2008).
Several mechanisms have been proposed 
to explain how pulmonary NP exposure can 
elicit cardio  vascular responses. One hypothe-
sis states that NPs deposited in the lung act 
through a neural mechanism to alter cardiac 
autonomic function (Nurkiewicz et al. 2006). 
A second hypothesis proposes that NPs depos-
ited in the lung initiate local inflammatory 
responses via oxidative stress that further 
develop into systemic oxidative stress/inflam-
mation (Yamawaki and Iwai 2006). A third 
hypothesis proposes that NPs deposited in the 
lung could trans  locate into the systemic circu-
lation and directly inter  act with cardio  vascular 
tissues to induce injury or inflammation 
(Yamawaki and Iwai 2006). Although there is 
evidence to support all three mechanisms (and 
they are not mutually exclusive), Brook (2008) 
suggested that the chronic effects of ambi-
ent particles upon the cardio  vascular system, 
such as athero  genesis, were mainly due to the   
generation of a chronic pro  inflammatory state. 
Recently, our group showed that inhala-
tion of nickel (Ni) hydroxide [Ni(OH)2] NPs 
(nano-NH), a material of growing interest 
in industry, including power/energy markets 
(Rocha et al. 2009), could induce significant 
pulmonary inflammation in mice in a dose-
dependent manner (Gillespie et al. 2010). 
Pulmonary inflammation can lead to systemic 
inflammation (Yamawaki and Iwai 2006), 
and given the association between systemic 
inflammation and various cardio  vascular 
diseases (Sin and Man 2003), it is logical to 
investigate possible cardio  vascular effects of 
inhaled nano-NH. Furthermore, some evi-
dence from other studies suggests that inhaled 
Ni can induce systemic cardio  vascular effects 
(Campen et al. 2001; Lippmann et al. 2006). 
Although the exact mecha  nisms behind these 
findings are still unclear, together these data 
suggest that inhaled nano-NH may induce sig-
nificant toxicity on the cardio  vascular system.
In this study, we investigated whether 
inhaled nano-NH could induce oxidative stress 
and inflammatory responses, not only in the 
lung but also in the extra  pulmonary organs, 
and whether long-term exposure could exacer-
bate the progression of athero  sclerosis in the 
apoprotein E-deficient (ApoE–/–) mouse, a 
sensitive animal model.
Materials and Methods
Animals. We used the ApoE–/– mouse, an 
animal model widely used to study the devel-
opment of athero  sclerosis. Male ApoE–/–   
mice were obtained from Taconic Farms 
(Germantown, NY) and housed in our ani-
mal facility, which is accredited by the 
Association for Assessment and Accreditation 
of Laboratory Animal Care. Animals were pro-
vided with standard rodent chow (TD7001, 
4% fat; Harlan Teklad, Indianapolis, IN) and 
water ad libitum. The mice were 5 months of 
age when exposures began and had at least 
a 2-week acclimation period before being 
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ba c K g R O u n d: Because associations have been reported between inhaled ambient ultrafine particles 
and increased risk of cardiopulmonary disease, it has been suggested that inhaled engineered nano-
particles (NPs) may also induce adverse effects on the cardio  vascular system.
Ob j e c t i v e: We examined the long-term cardio  vascular effects of inhaled nickel hydroxide NPs 
(nano-NH) using a sensitive mouse model.
Me t h O d s : Hyperlipidemic, apoprotein E-deficient (ApoE–/–) mice were exposed to nano-NH at 
either 0 or 79 μg Ni/m3, via a whole-body inhalation system, for 5 hr/day, 5 days/week, for either 
1 week or 5 months. We measured various indicators of oxidative stress and inflammation in the 
lung and cardio  vascular tissue, and we determined plaque formation on the ascending aorta. 
Re s u l t s: Inhaled nano-NH induced significant oxidative stress and inflammation in the pulmonary 
and extra    pulmonary organs, indicated by up-regulated mRNA levels of certain anti  oxidant enzyme 
and inflammatory cytokine genes; increased mitochondrial DNA damage in the aorta; significant 
signs of inflammation in broncho  alveolar lavage fluid; changes in lung histopathology; and induction 
of acute-phase response. In addition, after 5-month exposures, nano-NH exacerbated the progression 
of athero  sclerosis in ApoE–/– mice.
cO n c l u s i O n s: This is the first study to report long-term cardio  vascular toxicity of an inhaled 
nanomaterial. Our results clearly demonstrate that long-term exposure to inhaled nano-NH can 
induce oxidative stress and inflammation, not only in the lung but also in the cardio  vascular system, 
and that this stress and inflammation can ultimately contribute to progression of athero  sclerosis in 
ApoE–/– mice.
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used for experiments. All procedures involv-
ing animals were conducted in compliance 
with guidelines for ethical animal research and 
approved by the New York University School 
of Medicine Animal Care and Use Committee. 
The animals were treated humanely and with 
regard for alleviation of suffering.
Exposure and sacrifice protocol. Details 
of nano-NH generation and a whole-body 
exposure system used in this study have been 
described previously (Gillespie et al. 2010). 
Animals were exposed either to filtered air (con-
trol) or to nano-NH at the nominal concentra-
tion of 100 µg Ni/m3 for 5 hr/day, 5 day/week, 
for either 1 week (1w; n = 6/group) or 5 months 
(5m; n = 16/group) and sacrificed 24 hr after 
the last day of exposure with an overdose of 
sodium pento  barbital via intra  peritoneal injec-
tion. The average exposure concentration during 
the study period was 78.6 µg Ni/m3 and 79.0 µg 
Ni/m3 for the 1w and 5m studies, respec-
tively [see Supplemental Material, Table 1a 
(doi:10.1289/ehp.1002508)]. Secondary uptake 
of nano-NH via ingestion from the material 
deposited on the exposure chamber or on the 
animal’s coat was considered negligible, based 
on preliminary analyses (Gillespie et al. 2010).
Ni content analyses. The organs of interest 
(lung, liver, heart, spleen, and whole blood) 
were removed from each animal, weighed, 
and wet-ashed in Teflon beakers using 
Optima-grade nitric acid and hydrogen per-
oxide (both from Fisher Scientific, Pittsburgh, 
PA). The samples were analyzed for Ni con-
tent using graphite furnace–atomic absorption 
spectroscopy (GF-AAS; model GF95; Thermo 
Scientific, Waltham, MA).
Bronchoalveolar lavage fluid (BALF) 
analyses. We used BALF to assess recruitment 
of neutrophils and protein leakage as markers 
of inflammatory responses and lung damage, 
respectively. Details of BALF analyses meth-
ods have been previously described (Gillespie 
et al. 2010).
Real-time reverse-transcriptase poly-
merase chain reaction (RT-PCR). To quan-
tify relative mRNA levels of the genes of 
interest in target tissue, real-time RT-PCR 
was performed using primer/probe sets 
from TaqMan Gene Expression Assays and 
the 7300 Real-Time PCR System (Applied 
Biosystems, Foster City, CA). Relative expres-
sion levels were established using the compar-
ative threshold cycle (CT) method outlined 
in the manufacturer’s instructions for the 
PCR system. All expression levels were nor-
malized to the housekeeping gene, hypoxan-
thine phospho  ribosyl  transferase (Hprt‑1) and 
reported as a relative fold change over con-
trol; see Supplemental Material (doi:10.1289/
ehp.1002508) for additional details. 
Long PCR for assessment of mitochon-
drial DNA (mtDNA) damage. To measure 
the relative amount of damaged mtDNA, we 
used a semi  quantitative long PCR assay, con-
ducted according to the protocol of Li et al. 
(2007), with slight modifications [for details, 
see Supplemental Material (doi:10.1289/
ehp.1002508)]. 
Serum analyses. Blood samples were col-
lected by heart puncture, and serum was 
separated and stored at –80°C until analysis. 
Serum levels of selected inflammatory markers 
were determined by the Luminex multi  plex 
system (Luminex Corp., Austin, TX), using 
commercial kits (BioRad, Hercules, CA). We 
meas  ured low-density lipo  protein (LDL) and 
total cholesterol levels using commercial kits 
(Thermo Scientific). 
Lung histopathology. The left lung lobes 
from each mouse were drop-fixed in 10% 
zinc-formalin (Fisher Scientific, Pittsburgh, 
PA) and then embedded in paraffin. Coronal 
sections (5 µm) stained with hematoxylin 
and eosin (H&E) were analyzed by a board-
certified pathologist with expertise in thoracic 
pathology (A.L.M.).
Plaque area quantification. The aorta was 
harvested and fixed in 10% zinc-formalin, 
embedded in paraffin, and cross-sectioned at 
a 5 µm for H&E staining. We determined 
the relative plaque area by meas  uring the size 
of athero  sclerotic lesions over the total aortic 
cross-sectional area, at four different locations 
of the ascending aorta separated by 80-µm 
intervals starting from the aortic root toward 
the aortic arch. Three consecutive sections 
were meas  ured for each location.
Statistical analyses. Differences between the 
two experimental groups were analyzed using 
Student’s t-test with equal or unequal variance 
depending on F-test results. For compari  sons 
among multiple groups, we used one-way analy-
sis of variance with either Tukey’s or Dunnet’s 
post hoc test. A p-value < 0.05 was considered 
significant. All statistical analyses were per-
formed using GraphPad Prism software (version 
5; GraphPad Software Inc., San Diego, CA). 
Results
Ni deposition and translocation. The diameter of 
primary nano-NH particles was approximately 
5 nm, and the count median diameter of 
agglomerates was 40 nm with a geometric SD 
of 1.50. Particle characteristics of nano-NH 
have been described previously (Gillespie et al. 
2010). The average exposure concentrations 
of nano-NH were 78.6 µg Ni/m3 and 79.0 µg 
Ni/m3 for 1w and 5m groups, respectively [see 
Supplemental Material, Table 1a (doi:10.1289/
ehp.1002508)], and these are < 10% of the 
current Occupational Safety and Health 
Administration (OSHA) permissible expo-
sure limit (PEL) for Ni(OH)2 (1 mg Ni/m3; 
TOXNET Toxicology Data Network 2003). 
Following both exposure periods, we assessed 
the lung Ni burden at 24 hr post  exposure. The 
average amounts of Ni found in the whole lung 
were 46.9 ng for the 1w group and 306.7 ng 
for the 5m group (see Supplemental Material, 
Table 1b). This indicates that continuous expo-
sure to nano-NH caused an accumulation of Ni 
in the lung over time, despite its relatively rapid 
clearance from the lung (~ 70% clearance in 
the first 24 hr), as reported previously (Gillespie 
et al. 2010). We also analyzed the liver, heart, 
spleen, and whole blood for Ni content but 
did not observe significant differences between 
nano-NH–exposed animals and control ani-
mals in any tissue. However, a slight but signifi-
cant increase (p < 0.05) in Ni concentration was 
observed in the whole blood of wild-type mice 
(C57BL/6) exposed to nano-NH at a higher 
concentration (~ 1,000 µg/m3) for 3 days [con-
trol, 8.17 ± 4.48 ng Ni/mL blood; nano-NH, 
24.33 ± 12.86 ng Ni/mL blood (Kang GS, 
Gillespie PA, Chen L-C, unpublished data). 
Oxidative stress induced by nano-NH expo-
sure. We determined mRNA levels of selected 
anti  oxidant enzymes [nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase 1 
(Nox‑1), super  oxide dismutase 2 (Sod‑2), thi-
oredoxin reductase 1 (Txnrd‑1), and heme 
oxygenase 1 (Ho‑1) in lung tissue. Of these 
genes, only Ho‑1 expression was changed. 
Ho‑1 was significantly up-regulated in both 1w 
and 5m exposure groups; the 5m group had 
a greater fold-increase than did the 1w group 
(Figure 1A). We consistently found no differ-
ence in mRNA abundance of Nox‑1, Sod‑2, or 
Figure 1. Markers of oxidative stress in mice after 1w or 5m nano-NH exposure (79 μg Ni/m3 nano-NH). 
(A) Relative Ho‑1 mRNA levels in various organs; values are mean ± SD (n = 6/group) expressed as relative 
fold increase over controls (normalized to 1; dashed line). (B) mtDNA damage in the aorta of ApoE–/– mice, 
determined by reduction in relative amplification compared with control (100%); values are mean ± SD 
(n = 6/group). Tissue samples were collected 24 hr after the last exposure. 
*p < 0.05, and **p < 0.01 compared with control. 
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Txnrd‑1 in the extra  pulmonary organs (spleen, 
heart, and aorta) from either exposure group 
(1w and 5m), but Ho‑1 expression was signifi-
cantly up-regulated in all three organs tested in 
the 5m group (Figure 1A). When we assessed 
mtDNA damage as a marker of oxidative stress 
specifically in the aorta, the results showed 
dramatically reduced amplification of aortic 
mtDNA in the 5m nano-NH–exposed mice, 
which reflects an increase in mtDNA damage, 
compared with control mice (Figure 1B). All 
these results suggest that long-term exposure to 
inhaled nano-NH can induce both pulmonary 
and systemic oxidative stress in ApoE–/– mice.
Pulmonary inflammation induced by 
nano-NH exposure. In BALF from both 1w 
and 5m exposure groups, we found signifi-
cant increases in total cell counts, neutro-
phil influx, and protein leakage (Figure 2), 
which indicate persistent inflammation and 
tissue injury induced by nano-NH exposure. 
For transcriptional changes in the lung tis-
sue, we assessed relative mRNA abundance 
of selected pro  inflammatory cyto  kines/
chemo  kines: chemokine (C-C motif) ligand 2 
(Ccl‑2), interleukin-6 (Il‑6), and tumor 
necrosis factor-α (Tnf‑α). In the 1w expo-
sure group, only Ccl‑2 and Il‑6 showed sig-
nificantly increased mRNA levels, whereas 
all three genes were up-regulated in the 5m 
exposure group (Figure 3A). The histopatho-
logical analysis also revealed distinct differ-
ences in the lung tissue between control and 
nano-NH–exposed mice in the 5m group. 
We observed mild to moderate inflamma-
tory infiltrate composed predominantly of 
large eosino  philic macro  phages and lympho-
cytes in the lung of nano-NH–exposed mice 
(Figure 4B). The inflammatory infiltrate was 
ill-defined and could be found in the peri-
bronchial and inter  stitial area of the lung. In 
addition, focal bronchiolitis was also pres-
ent. In contrast, the lungs of control mice 
appeared normal with no significant inflam-
matory infiltrate (Figure 4A). These results are 
consistent in indicating persistent pulmonary 
inflammation induced by nano-NH exposure.
Systemic inflammation induced by 
nano-NH exposure. Serum amyloid P com-
ponent (SAP) is a major acute-phase protein 
in the mouse that is produced mainly by 
Kupffer cells in the liver following injury or 
inflammation. Thus, we assessed the abun-
dance of Sap mRNA in the livers of mice as 
a sensitive marker of systemic inflammation 
and found significantly increased levels after 
exposure to nano-NH in both the 1w group 
(3.5-fold) and the 5m group (3.6-fold) [see 
Supplemental Material, Figure 1 (doi:10.1289/
ehp.1002508)]. Other markers of systemic 
inflammation used in this study were the 
mRNA levels of pro  inflammatory cytokines 
and chemokines in the heart and spleen. We 
measured relative mRNA levels of Ccl‑2, Il‑6, 
and Tnf‑α in each organ (Figure 3B,C). In 
the 1w exposure group, we observed no sig-
nificant transcriptional changes in either organ. 
However, in the 5m exposure group, Ccl‑2 
and Il‑6 were up-regulated in the heart, and 
all three genes were up-regulated in the spleen. 
These findings suggest that prolonged expo-
sure to inhaled nano-NH can induce systemic 
inflammatory responses in extra  pulmonary 
organs such as the heart and spleen, although 
no significant difference was observed in serum 
levels of those cytokines/chemokines between 
control and nano-NH groups.
Progression of athero  sclerosis. To determine 
the relative degree of progression of athero-
sclerosis, we measured relative plaque area using 
cross-sectional slides of the ascending aorta. At 
all four locations of the ascending aorta (with 
80-µm intervals from the aortic root), mice 
in the 5m nano-NH exposure group had sig-
nificantly greater lesion area than did control 
mice (Figure 5A,C,D). We found no differ-
ence in plaque size among locations. Overall, 
plaque formation in the ascending aorta of 
the 5m exposure group was approximately 
1.8 times that of the controls (Figure 5A). In 
addition, we selected three genes involved in 
athero  genesis, Ccl‑2, vascular cell adhesion 
molecule 1 (Vcam‑1), and cluster of differentia-
tion 68 (Cd68), and determined their mRNA 
levels in thoracic aorta tissue. mRNA levels of 
all three genes increased significantly in the 5m 
exposure group (Figure 5B). To test whether 
nano-NH exposure affected lipid metabolism 
in mice, we meas  ured serum levels of LDL 
and total cholesterol. Neither marker showed 
signifi  cant differences between nano-NH and 
control groups after both exposure periods 
(data not shown).
Discussion
To the best of our knowledge, this is the first 
study to investigate long-term cardio  vascular 
toxicity of an inhaled nano  material. Our results 
clearly demonstrate that sub    chronic inhalation 
exposure to nano-NH can induce significant 
cardio  vascular effects including exacerbation of 
athero  sclerosis in ApoE–/– mice.
After exposure to inhaled nano-NH, 
ApoE–/– mice showed signs of both pulmonary 
and extra  pulmonary oxidative stress, such as 
marked transcriptional up-regulation of Ho‑1 
in the lungs and other tissues (spleen, heart, 
Figure 2. Pulmonary responses measured in BALF in mice after 1w or 5m nano-NH exposure (79 μg Ni/m3 
nano-NH). (A) Total cell counts. (B) Number of neutrophils. (C) Total protein concentration. All markers were 
measured 24 hr after the last exposure; values are mean ± SD (n = 6/group). 
**p < 0.01 compared with control. 
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and aorta) and mtDNA damage in the aorta. 
We chose to measure Ho‑1 expression because 
it has been widely used as a sensitive marker for 
oxidative stress, especially in particle-mediated 
toxicity studies (Eom and Choi 2009; Lund 
et al. 2007; McDonald et al. 2010). Ho‑1 is 
transcriptionally up-regulated by various types 
of oxidative stress (Anwar et al. 2005) and 
is highly expressed in athero  sclerotic lesions 
(Ishikawa 2003). Our results clearly show 
that exposure to inhaled nano-NH increased 
mRNA levels of Ho‑1 in the lung in both 1w 
and 5m exposure groups and also in the heart, 
spleen, and aorta in the 5m exposure group. 
Up-regulation of Ho‑1 in the aorta was espe-
cially interesting because it coincided with 
increased aortic mtDNA damage. It has been 
suggested that Ho‑1 inhibits oxidized LDL-
dependent mono  cyte chemo  taxis, and there-
fore, Ho‑1 induction can act as a protective 
mechanism against vascular injuries (Ishikawa 
2003). On the other hand, mtDNA is known 
to be highly susceptible to oxidative stress, and 
the role of mtDNA damage in various human 
diseases related to oxidative stress, includ-
ing athero  sclerosis, has been widely studied 
(Ballinger 2005). mtDNA damage in both 
human and mouse vascular tissues has been 
correlated with the extent of athero  sclerosis 
(Puddu et al. 2005), and it has also been sug-
gested to be an initiating event in athero  genesis 
(Ballinger et al. 2002). Therefore, the fact that 
there was significant mtDNA damage in the 
aorta in the 5m nano-NH exposure group 
despite up-regulated Ho‑1 suggests that oxi-
dative stress produced by inhaled nano-NH 
overwhelmed the capacity of Ho‑1–related 
defense mechanisms to fully compensate for 
the nano-NH–induced oxidative stress.
We have also shown that pulmonary and 
systemic inflammation is induced by inhaled 
nano-NH. To assess pulmonary inflamma-
tion, we used commonly studied markers such 
as neutrophil influx and protein leakage in 
BALF, mRNA levels of major inflammatory 
cyto  kines and chemo  kines, and histological 
analyses. The results of all of these analyses 
indicate that significant and persistent pul-
monary inflammation was caused by inhaled 
nano-NH. Further, we found that some of 
the same inflammatory cytokine and chemo-
kine genes that were up-regulated in the 
lung were also up-regulated in the heart and 
spleen, suggesting systemic inflammation. 
One of the interesting end points used in 
this study to measure systemic inflammation 
was hepatic mRNA levels of a mouse acute-
phase protein, Sap. Although C-reactive pro-
tein, a major acute-phase protein in humans, 
has been widely studied as a biomarker for 
cardio  vascular disease in humans, few stud-
ies have investigated acute-phase responses 
in the mouse. Because SAP is a major acute-
phase protein in the mouse (Saber et al. 2009; 
Whitehead et al. 1990), we assessed the level 
of Sap mRNA in the liver as a sensitive marker 
for systemic inflammation. In both exposure 
groups (1w and 5m), Sap mRNA levels in the 
liver increased significantly compared with 
controls, further suggesting the induction of 
systemic inflammation by inhaled nano-NH.
To determine the effects of inhaled 
nano-NH on development of athero    sclerosis in 
ApoE–/– mice, we quantified plaque formation 
on the ascending aorta. We chose the ascending 
aorta as the site of measure  ment because it is 
known to have a predilection for develop  ment 
of athero  sclerosis in ApoE–/– mice (Nakashima 
et al. 1994), and the plaque area of this site 
is closely correlated to total plaque burden of 
the entire aorta (Gan et al. 2007). At all four 
locations selected on the ascending aorta, the 
mice in the 5m nano-NH exposure group had 
significantly larger plaques (~ 1.8-fold) than 
the control mice. We sought to identify charac-
teristics of the plaques that might provide 
insights to mechanisms that could explain the 
acceleration of plaque formation in nano-NH–
exposed mice. Hence, we measured the abun-
dance of Ccl‑2, Vcam‑1, and Cd68 transcripts 
Figure 4. Effects of 5m exposure to nano-NH (79 μg Ni/m3 nano-NH shown by histopathological analysis 
of the mouse lung. Representative H&E-stained images from (A) a control mouse showing open alveolar 
spaces and no inflammatory infiltrate and (B) a nano-NH–exposed mouse showing an ill-defined inflam-
matory nodule composed predominantly of large eosinophilic macrophages infiltrating the pulmonary 
parenchyma; bars = 0.1 mm. Tissue samples were collected 24 hr after the last exposure. 
Figure 5. Effects of nano-NH exposure (79 μg Ni/m3 nano-NH) on progression of athero  sclerosis. 
(A) Relative plaque area at four different locations of the ascending aorta (at 80-μm intervals) in the 5m 
group; values are expressed as mean ± SD (n = 7/group). (B) Relative mRNA levels of Ccl‑2, Vcam‑1, and 
Cd68 in aortas from the 1w and 5m exposure groups; values are mean ± SD (n = 6/group) expressed as 
relative fold increase over controls (normalized to 1; dashed line). (C and D) Photomicrographs of rep-
resentative H&E-stained aortic cross-sections from control (C) and nano-NH (D) mice in the 5m group; 
bars = 0.2 mm. All tissue samples were collected 24 hr after the last exposure. 
**p < 0.01 compared with control. 
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in the aorta. Ccl‑2 is well known for its involve-
ment in monocyte adhesion during the early 
development of athero  sclerosis (Kusano et al. 
2004). Vcam‑1 is an adhesion molecule that 
is expressed on activated endothelial cells and 
known to promote mono  cyte adhesion and 
accumulation on the vessel wall in the initia-
tion stage of athero  sclerosis (Ma et al. 2008). 
Cd68 is a macrophage-specific marker (Graebe 
et al. 2009) and has been widely used as an 
indicator of macrophage infiltration into the 
endothelium during athero  genesis (Moreno 
et al. 2000; Tearney et al. 2003). We found 
that all three genes were up-regulated in the 
5m nano-NH exposure group. These results 
provide plausible molecular mechanisms for 
the increase in athero  sclerotic lesion area in 
mice exposed to nano-NH for 5 months.
Another end point we measured because of 
its association with athero  sclerosis was serum 
cholesterol. Lipid is one of the most studied 
and most important stimuli initiating athero-
genesis (Mehra et al. 2005), and extra  cellular 
accumulation of lipids occurs early in response 
to increased plasma lipoprotein levels in ani-
mals (Skalen et al. 2002). Here we found no 
significant differences in serum LDL or total 
cholesterol levels between nano-NH–exposed 
and control mice, which suggests that the 
increase in plaque formation after nano-NH 
exposure might be due to other mechanisms 
contributing to athero  genesis, such as systemic 
oxidative stress and/or inflammation.
Although many epidemiological and experi-
mental studies have shown the association 
between inhaled ambient particles and cardio-
vascular effects, the mechanistic basis of this 
association remains largely unknown. Brook 
(2008) proposed generation of a chronic pro-
inflammatory state as a major mechanism for 
chronic effects of ambient particles upon the 
cardio  vascular system. A key question regard-
ing this potential mechanism is whether a sys-
temic pro  inflammatory state is induced by 
mediators secreted from the exposed lung or 
the result of direct inter  action between trans-
located particles and local tissues.
In a recent study, Mitchell et al. (2009) 
suggested that tumor growth factor-β released 
from the lung of mice after inhalation exposure 
to multi  walled carbon nanotubes could induce 
the cyclo  oxygenase pathway in the spleen, 
leading to systemic immune responses. Their 
finding was especially interesting because the 
mice did not show any overt lung inflamma-
tion. Considering the signs of significant pul-
monary inflammation in nano-NH–exposed 
mice, it is possible that certain mediators 
released from the inflamed lung could have 
induced further systemic effects in the present 
study as well. However, we found that most 
markers for systemic effects showed signifi-
cant changes only in the 5m group, not in the 
1w group, whereas signs of strong pulmonary 
inflammation were evident in the 1w exposure 
group. This suggests that some of the observed 
systemic effects (i.e., increased mRNA levels in 
extra  pulmonary tissues) may be due to the per-
sistent inter  action of small quantities of trans-
located nano-NH with target tissues over time. 
Although we found no significant differences 
in Ni content between control and nano-NH–
exposed groups in the heart, liver, or spleen, 
this is not surprising considering that a) our 
exposure concentration was fairly low and 
b) Ni had relatively high baseline levels and 
large individual variation, probably due to its 
relatively high content in rodent chow (2–3 
µg Ni/g chow). Furthermore, we observed a 
slight but statistically significant increase in Ni 
concentration in the blood after a 3-day expo-
sure to a higher concentration of nano-NH 
(~ 1,000 µg/m3) in wild-type C57BL/6 mice 
(Kang GS, Gillespie PA, Chen L-C, unpub-
lished data). This may be an indication of 
trans  location, supporting the hypothesis of 
adverse systemic effects caused by transloca-
tion of NPs. In a recent study, Wallenborn 
et al. (2007) showed that ambient particulate 
matter–associated metals (including Ni) were 
rapidly trans  located to the circulation after 
intra  tracheal instillation, and this transloca-
tion was dependent on the solubility of metals. 
Given the high dissolution rate of nano-NH 
[~ 86% within 24 hr in physiological buffer 
(Gillespie et al. 2010)], it is possible that a 
fraction of inhaled nano-NH was trans  located 
to systemic circulation and accumulated in 
extra  pulmonary organs over time. Future stud-
ies using Ni-deficient chow and more sensitive 
analytical methods to detect minute changes 
in serum inflammatory markers, as well as Ni 
translocation, may assist in further elucidating 
the mechanisms of systemic effects caused by 
inhaled nano-NH.
One of the major strengths of the present 
study is that by using a whole-body inhalation 
system and an occupationally realis  tic expo-
sure concentration, the exposure conditions 
were relevant to human exposure scenarios. 
Inhalation exposure is considered the gold 
standard for assessing the toxicity of airborne 
materials (Elder 2009), and in our previous 
study (Gillespie et al. 2010), we described key 
advantages of using a whole-body exposure 
system. In addition, we used an exposure con-
centration that is < 10% of the current occu-
pational guideline (OSHA PEL) for Ni(OH)2. 
Although no actual workplace exposure data 
have yet been reported for nano-NH, 79 µg 
Ni/m3 is relatively low compared with the 
occupational exposure concentrations in other 
industries using Ni (Sivulka et al. 2007). 
Conclusion
The results of our study clearly demon  strate 
that inhaled nano-NH induced significant 
oxidative stress and inflammation in the 
pulmonary and extra  pulmonary organs. In 
addition, over the long-term (5 months), 
nano-NH exacerbated the progression of 
athero  sclerosis in a sensitive mouse model. 
We believe that these findings will contrib-
ute to the further under  standing of potential 
risks and mechanisms of NP-induced toxicity 
and to establishing a database for NP-specific 
regulations in occupational settings.
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